Clinical Trial

MagDI Canada Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel clinical procedure requiring a side-to-side anastomosis. The secondary objective includes initial efficacy of the duodeno-ileal diversion using the MagDI System.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-06-19; most recent amendment 2026-05-18.
Status change: Recruiting → Active, Not Recruiting 2026-05-18
Trial Details
NCT Number NCT06467955
Lead Sponsor GT Metabolic Solutions, Inc.
Conditions Obesity, Type 2 Diabetes
Enrollment 60 participants
Start Date 2024-05-10
Primary Completion 2026-01-27 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-20